Indications and uses
temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever
temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever
do not take more than directed (see overdose warning ) adults and children 12 years and over take 2 caplets every 6 hours while symptoms last do not take more than 6 caplets in 24 hours, unless directed by a doctor do not use for more than 10 days unless directed by a doctor children under 12 years ask a doctor
store between 20-25°C (68-77°F) do not use if carton is opened. Do not use if foil inner seal imprinted with "TYLENOL" is broken or missing
Drug Facts
Acetaminophen 500 mg
Pain reliever/fever reducer
This product contains acetaminophen. Severe liver damage may occur if you take
Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
Ask a doctor before use if you have liver disease
Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin
These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222) Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
| adults and children 12 years and over |
|
| children under 12 years | ask a doctor |
carnauba wax, crospovidone, FD&C red no. 40 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, pregelatinized starch, propylene glycol, shellac glaze, sodium starch glycolate, stearic acid, titanium dioxide
call 1-877-895-3665 (toll-free) or 215-273-8755 (collect)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | 16 |
| 209459 | Tylenol Extra Strength 500 MG Oral Tablet | PSN | 16 |
| 209459 | acetaminophen 500 MG Oral Tablet [Tylenol] | SBD | 16 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | 16 |
| 198440 | APAP 500 MG Oral Tablet | SY | 16 |
| 209459 | APAP 500 MG Oral Tablet [Tylenol] | SY | 16 |
| 209459 | Tylenol 500 MG Oral Tablet | SY | 16 |
| 209459 | Tylenol Extra Strength 500 MG Oral Tablet | SY | 16 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50580-378-01 | Tylenol Extra Strength | 24 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 24 | 16 | |
| 50580-378-01 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 50580-378-02 | Tylenol Extra Strength | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 16 | |
| 50580-378-02 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 50580-378-03 | Tylenol Extra Strength | 225 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 225 | 16 | |
| 50580-378-04 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 50580-378-04 | Tylenol Extra Strength | 24 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 24 | 16 | |
| 50580-378-05 | Tylenol Extra Strength | 50 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 50 | 16 | |
| 50580-378-05 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 50580-378-06 | Tylenol Extra Strength | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 16 | |
| 50580-378-06 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 50580-378-07 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 50580-378-07 | Tylenol Extra Strength | 225 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 225 | 16 | |
| 50580-378-08 | Tylenol Extra Strength | 325 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 325 | 16 | |
| 50580-378-37 | Tylenol Extra Strength | 320 in 1 BOTTLE | TABLET, FILM COATED | 320 | 16 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-378-02 | EA - Each | 50580-378 | c823b137-4e5c-42cc-8af6-1224282ef2cd | 1 | 2017-04-05 |
| 50580-378-37 | EA - Each | 50580-378 | e15f0786-655c-4c38-822f-8ac424833570 | 1 | 2026-04-20 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Acetaminophen | ACTIVE INGREDIENT | 362O9ITL9D | 1 | |
| Acetaminophen | ACTIVE MOIETY | 362O9ITL9D | 1 | |
| aluminum oxide | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| crospovidone | INACTIVE INGREDIENT | 68401960MK | 1 | |
| FD&C red no. 40 | INACTIVE INGREDIENT | WZB9127XOA | 1 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| polyethylene glycols | INACTIVE INGREDIENT | 3WJQ0SDW1A | 1 | |
| polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 1 | |
| povidones | INACTIVE INGREDIENT | FZ989GH94E | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| shellac | INACTIVE INGREDIENT | 46N107B71O | 1 | |
| sodium starch glycolate type A potato | INACTIVE INGREDIENT | 5856J3G2A2 | 1 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50580-378 | 50580-378-01, 50580-378-02, 50580-378-03, 50580-378-04, 50580-378-05, 50580-378-06, 50580-378-07, 50580-378-08, 50580-378-37 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 15 | 2026-01-13 | monthly-update | 2026-06-03 17:52:55 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED / ORAL | 24 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| shellac | SHELLAC | 46N107B71O | TABLET, FILM COATED / ORAL | 4.4 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| shellac | SHELLAC | 46N107B71O | TABLET, FILM COATED / ORAL | 4.4 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED / ORAL | 24 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| shellac | SHELLAC | 46N107B71O | TABLET, FILM COATED / ORAL | 4.4 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED / ORAL | 24 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| shellac | SHELLAC | 46N107B71O | TABLET, FILM COATED / ORAL | 4.4 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| shellac | SHELLAC | 46N107B71O | TABLET, FILM COATED / ORAL | 4.4 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED / ORAL | 24 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED / ORAL | 24 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tylenol Extra Strength | ACETAMINOPHEN | Kenvue Brands LLC | 17cfa99d-abb2-4d77-9e0e-e77109fbb61a | 2026-01-21 | Warnings | 50580-378-04 50580-378-05 50580-378-07 50580-378-08 50580-378-02 50580-378-37 50580-378-06 50580-378-01 50580-378-03 50580-378 50580037807 50580037837 50580037806 50580037808 50580037804 50580037801 50580037803 50580037805 50580037802 48dff3c9-329f-1300-e063-6294a90a47ef 17cfa99d-abb2-4d77-9e0e-e77109fbb61a |
Adverse event summaries are temporarily unavailable. Other product information remains available.